GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 81 filers reported holding GALENA BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $212,000 | -30.0% | 601,414 | -7.4% | 0.00% | – |
| Q2 2016 | $303,000 | -63.9% | 649,316 | +5.2% | 0.00% | – |
| Q1 2016 | $839,000 | +1.3% | 617,026 | +9.5% | 0.00% | – |
| Q4 2015 | $828,000 | -11.0% | 563,402 | -4.3% | 0.00% | – |
| Q3 2015 | $930,000 | -19.5% | 588,738 | -13.3% | 0.00% | – |
| Q2 2015 | $1,155,000 | +34.3% | 679,340 | +9.8% | 0.00% | – |
| Q1 2015 | $860,000 | +1.8% | 618,927 | +10.7% | 0.00% | – |
| Q4 2014 | $845,000 | -30.3% | 558,920 | -5.1% | 0.00% | – |
| Q3 2014 | $1,213,000 | -67.6% | 589,016 | -51.8% | 0.00% | -100.0% |
| Q2 2014 | $3,740,000 | +169.3% | 1,222,408 | +120.1% | 0.00% | – |
| Q1 2014 | $1,389,000 | -46.8% | 555,351 | +5.6% | 0.00% | -100.0% |
| Q4 2013 | $2,609,000 | +26.7% | 526,058 | -41.8% | 0.00% | – |
| Q3 2013 | $2,060,000 | +130.9% | 903,106 | +124.6% | 0.00% | – |
| Q2 2013 | $892,000 | – | 402,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,446,469 | $13,616,000 | 2.03% |
| Harbour Capital Advisors, LLC | 78,450 | $196,000 | 0.19% |
| SABBY MANAGEMENT, LLC | 708,089 | $1,770,000 | 0.10% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 174,600 | $437,000 | 0.07% |
| Alyeska Investment Group, L.P. | 530,000 | $1,950,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 528,027 | $1,320,000 | 0.05% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $295,000 | 0.05% |
| Quantitative Investment Management, LLC | 348,500 | $871,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 538,100 | $1,345,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $74,000 | 0.04% |